Opportunity Information: Apply for RFA AT 24 009

The REsearch Across Complementary and Integrative Health Institutions (REACH) Virtual Resource Centers funding opportunity (RFA-AT-24-009) is a National Institutes of Health (NIH) cooperative agreement (U24) from the National Center for Complementary and Integrative Health (NCCIH) designed to strengthen research capacity and research training at accredited complementary and integrative health (CIH) clinical institutions. Rather than funding a single research study, this program supports the creation of virtual, partnership-based resource centers that help CIH clinician-scientist faculty become more competitive for external research funding and more connected to multidisciplinary research networks. Clinical trials are not allowed under this U24, and the emphasis is on building infrastructure, support services, and collaboration pathways that enable higher-quality clinical research planning and grant submissions.

At its core, REACH aims to foster institutional partnerships across CIH schools and related organizations, especially in fields such as acupuncture, chiropractic, osteopathy, naturopathy, physical therapy, and music and art therapy. The centers are expected to operate virtually, meaning the main value is in shared expertise, coordinated support, and accessible resources that can reach investigators across multiple sites, even if they are geographically dispersed. The program is closely tied to NCCIH strategic priorities in symptom management, so applicants should expect that the support they provide to investigators (for example, topic selection, proposal refinement, and team formation) should align with symptom-focused research priorities relevant to NCCIH.

REACH virtual resource centers are expected to offer a menu of practical services that directly address common barriers faced by clinician-scientist faculty at CIH institutions. The NOFO highlights several core categories of support: administrative support (help with coordination, operations, compliance-oriented guidance, and logistical backbone), research support (study design consultation, methods support, data-related planning, and navigation of research processes), grantsmanship (help with identifying opportunities, crafting competitive NIH-style applications, responsiveness to review criteria, and strengthening specific aims), mentoring and training (structured guidance for investigators at different career stages, skills development, and ongoing professional development), and team building (facilitating collaborations across disciplines and institutions, connecting clinicians with methodologists, and creating multi-institutional partnerships). The intent is to help clinician scientists form multi- and interdisciplinary teams capable of conducting rigorous clinical research and competing successfully for federal funding.

Importantly, the program is oriented toward supporting investigators pursuing clinical research that is not a clinical trial. Examples called out include observational studies, epidemiological research, mechanistic clinical research, mixed methods research, and feasibility studies. In practice, this means the virtual centers should be prepared to help faculty develop strong, fundable research questions; choose appropriate designs and measures; address feasibility and implementation realities in clinical environments; and build the kinds of collaborations and preliminary groundwork that reviewers often expect. Since the U24 mechanism is a cooperative agreement, NIH typically has substantial programmatic involvement compared with a standard grant, so awardees should anticipate active coordination with NCCIH staff and a focus on well-defined milestones, deliverables, and measurable outcomes.

The NOFO lays out clear expected outcomes for these centers. First, they should improve both the quality and the quantity of federal grant applications submitted by clinician-scientist faculty at CIH institutions, meaning more submissions and stronger submissions that are better aligned to NIH expectations. Second, they should actively promote the formation of multi- and interdisciplinary partnerships across participating CIH institutions, building networks that outlast any single proposal and make collaboration routine rather than exceptional. Third, they should help strengthen the overall research environment at CIH institutions by normalizing research activity, improving access to expertise and support, and reducing institutional friction points that can derail promising investigators. Fourth, they should help develop a pipeline of clinician scientists trained in CIH practices who can pursue sustained research careers in clinical institutional settings, which implies attention to mentorship structures, skills development, and career progression support.

Eligibility is broad and includes many common U.S.-based organizational types, such as state, county, and local governments; public and private institutions of higher education; independent school districts; special district governments; federally recognized tribal governments and certain tribal organizations; public housing authorities/Indian housing authorities; nonprofit organizations with or without 501(c)(3) status; for-profit organizations (other than small businesses) and small businesses; and other organizations as allowed by NIH policy. The NOFO also explicitly mentions additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible agencies of the federal government, regional organizations, and U.S. territories or possessions. Non-U.S. (foreign) organizations are not eligible to apply, and non-U.S. components of U.S. organizations are not eligible; however, foreign components as defined in the NIH Grants Policy Statement are allowed, which typically means certain project elements may occur abroad under specific conditions and approvals while the applicant organization remains U.S.-based.

Key administrative details provided include the original closing date of 2024-09-07, a maximum award amount (award ceiling) of $850,000, and the CFDA number 93.213. The overall activity category is health, and the opportunity is discretionary. While the notice excerpt does not specify the exact number of expected awards in the provided text, it indicates that awards are anticipated and that applicants should plan around the cooperative, deliverables-driven nature of a U24 center program rather than a single research project budget structure.

In practical terms, a competitive REACH application would typically describe a well-organized virtual center with clear leadership, defined partner institutions, a concrete set of core services, and a credible plan for reaching and supporting clinician-scientist faculty across participating CIH institutions. It would also be expected to show how the center will track outcomes (such as submissions, resubmissions, scores, funding outcomes, partnership formation, and training participation), how it will deliver consistent mentoring and methods support, and how it will build sustainable research culture and collaboration pathways aligned with NCCIH symptom management priorities, all while staying within the boundary that clinical trials are not allowed under this specific U24 opportunity.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "REsearch Across Complementary and Integrative Health Institutions (REACH) Virtual Resource Centers (U24 Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.213.
  • This funding opportunity was created on 2024-06-03.
  • Applicants must submit their applications by 2024-09-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $850,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA AT 24 009

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: NCI Outstanding Investigator Award (R35)

Previous opportunity: Cooperative Agreement for CESU-affiliated Partner with Colorado Plateau Cooperative Ecosystem Studies Unit

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA AT 24 009

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA AT 24 009) also looked into and applied for these:

Funding Opportunity
Service Area Competition – Additional Area Apply for HRSA 25 087

Funding Number: HRSA 25 087
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
T32 Training Program for Institutions That Promote Diversity (T32 Clinical Trial Not Allowed) Apply for PAR 24 199

Funding Number: PAR 24 199
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Mechanistic Investigations into ADRD Associated Protein Structures in Biological Settings (R01 - Clinical Trial Not Allowed) Apply for PAR 24 234

Funding Number: PAR 24 234
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
PEPFAR Uganda Community Grants to Combat HIV/AIDS Apply for DOS UGA SMGCG FY25

Funding Number: DOS UGA SMGCG FY25
Agency: Bureau of African Affairs
Category: Health
Funding Amount: $15,000
Service Area Competition Apply for HRSA 25 014

Funding Number: HRSA 25 014
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
Service Area Competition Apply for HRSA 25 015

Funding Number: HRSA 25 015
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
Community Level Interventions to Improve Minority Health and Reduce Health Disparities (R01 - Clinical Trial Optional) Apply for PAR 24 231

Funding Number: PAR 24 231
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,000,000
Clinical Trial Readiness to Understand and Develop Solutions to Social, Ethical, Behavioral Implications and Barriers to Health Equity in ADRD (R01 - Clinical Trial Not Allowed) Apply for RFA NS 25 013

Funding Number: RFA NS 25 013
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Ensuring Accessibility to Quality HIV Services in Kazakhstan (SAPA) Apply for 72011524RFA00008

Funding Number: 72011524RFA00008
Agency: Kazakhstan USAID-Almaty
Category: Health
Funding Amount: $800,000
Research Collaboration Network in Structural Racism Measurement and Modeling (U24 Clinical Trial Optional) Apply for RFA AG 25 003

Funding Number: RFA AG 25 003
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,000,000
Delta Health Care Service Grant Program Apply for RDBCP DHCS 2024

Funding Number: RDBCP DHCS 2024
Agency: Rural Business-Cooperative Service
Category: Health
Funding Amount: $1,000,000
USAID The Gambia Malaria Elimination Activity Apply for 72068524RFA00016

Funding Number: 72068524RFA00016
Agency: Senegal USAID-Dakar
Category: Health
Funding Amount: $13,000,000
Pilot Research Opportunities in Crisis Response Services for Suicide Prevention (R34 Clinical Trial Optional) Apply for RFA MH 25 136

Funding Number: RFA MH 25 136
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Research Opportunities in Crisis Response Services for Suicide Prevention (R01 Clinical Trial Optional) Apply for RFA MH 25 135

Funding Number: RFA MH 25 135
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Assessing Use of Health IT by U.S. Physicians Providing Outpatient Care Apply for NAP AX 24 001

Funding Number: NAP AX 24 001
Agency: Office of the National Coordinator
Category: Health
Funding Amount: $425,000
Ending the HIV/HCV/Syphilis Epidemics in Indian Country II (ETHIC II): A Syndemic Elimination Program for American Indian and Alaska Native Tribes and Urban Indian Communities Apply for HHS 2024 IHS ETHIC 0001

Funding Number: HHS 2024 IHS ETHIC 0001
Agency: Indian Health Service
Category: Health
Funding Amount: $2,000,000
Mechanisms of Inducing HIV Immunity in Early Life (MIEL) (U01 Clinical Trial Not Allowed) Apply for RFA AI 24 029

Funding Number: RFA AI 24 029
Agency: National Institutes of Health
Category: Health
Funding Amount: $750,000
Limited Competition: NIMHD Initiative for Improving American Indian and Alaska Native Cancer Outcomes (U19 - Clinical Trial Optional) Apply for RFA MD 24 009

Funding Number: RFA MD 24 009
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
PEPFAR Community-Led Monitoring (CLM) Grant Apply for 2025 PECO GRANT01

Funding Number: 2025 PECO GRANT01
Agency: U.S. Mission to Ethiopia
Category: Health
Funding Amount: $600,000
NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Clinical Trials and Clinical Research (R44 Clinical Trial Optional) Apply for PAR 24 221

Funding Number: PAR 24 221
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA AT 24 009", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: